These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
651 related items for PubMed ID: 26878795
21. Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis. Lee C, Lee JW, Seo JY, Hwang SW, Im JP, Kim JS. Life Sci; 2016 Feb 01; 146():100-8. PubMed ID: 26767626 [Abstract] [Full Text] [Related]
22. Monotropein isolated from the roots of Morinda officinalis ameliorates proinflammatory mediators in RAW 264.7 macrophages and dextran sulfate sodium (DSS)-induced colitis via NF-κB inactivation. Shin JS, Yun KJ, Chung KS, Seo KH, Park HJ, Cho YW, Baek NI, Jang D, Lee KT. Food Chem Toxicol; 2013 Mar 01; 53():263-71. PubMed ID: 23261679 [Abstract] [Full Text] [Related]
23. Stevioside, a diterpenoid glycoside, shows anti-inflammatory property against Dextran Sulphate Sodium-induced ulcerative colitis in mice. Alavala S, Sangaraju R, Nalban N, Sahu BD, Jerald MK, Kilari EK, Sistla R. Eur J Pharmacol; 2019 Jul 15; 855():192-201. PubMed ID: 31075241 [Abstract] [Full Text] [Related]
24. Cepharanthine Exerts Antioxidant and Anti-Inflammatory Effects in Lipopolysaccharide (LPS)-Induced Macrophages and DSS-Induced Colitis Mice. Chen G, Wen D, Shen L, Feng Y, Xiong Q, Li P, Zhao Z. Molecules; 2023 Aug 15; 28(16):. PubMed ID: 37630322 [Abstract] [Full Text] [Related]
25. The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation. Cui L, Feng L, Zhang ZH, Jia XB. Int Immunopharmacol; 2014 Nov 15; 23(1):294-303. PubMed ID: 25239813 [Abstract] [Full Text] [Related]
26. Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice. Zhao ZJ, Xiang JY, Liu L, Huang XL, Gan HT. Int Immunopharmacol; 2012 Jan 15; 12(1):169-74. PubMed ID: 22155740 [Abstract] [Full Text] [Related]
27. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Endale M, Park SC, Kim S, Kim SH, Yang Y, Cho JY, Rhee MH. Immunobiology; 2013 Dec 15; 218(12):1452-67. PubMed ID: 23735482 [Abstract] [Full Text] [Related]
28. Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model. Qiu J, Chi G, Wu Q, Ren Y, Chen C, Feng H. Int Immunopharmacol; 2016 Feb 15; 31():109-15. PubMed ID: 26710167 [Abstract] [Full Text] [Related]
29. Dietary squalene supplementation improves DSS-induced acute colitis by downregulating p38 MAPK and NFkB signaling pathways. Sánchez-Fidalgo S, Villegas I, Rosillo MÁ, Aparicio-Soto M, de la Lastra CA. Mol Nutr Food Res; 2015 Feb 15; 59(2):284-92. PubMed ID: 25387687 [Abstract] [Full Text] [Related]
30. The p38 MAPK inhibitor JLU1124 inhibits the inflammatory response induced by lipopolysaccharide through the MAPK-NF-κB pathway in RAW264.7 macrophages. Li XN, Su J, Zhao L, Xiang JB, Wang W, Liu F, Li HY, Zhong JT, Bai X, Sun LK. Int Immunopharmacol; 2013 Nov 15; 17(3):785-92. PubMed ID: 24070708 [Abstract] [Full Text] [Related]
31. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS. Inflamm Bowel Dis; 2006 Dec 15; 12(12):1152-61. PubMed ID: 17119390 [Abstract] [Full Text] [Related]
32. Protective effect of galangin against dextran sulfate sodium (DSS)-induced ulcerative colitis in Balb/c mice. Sangaraju R, Nalban N, Alavala S, Rajendran V, Jerald MK, Sistla R. Inflamm Res; 2019 Aug 15; 68(8):691-704. PubMed ID: 31147743 [Abstract] [Full Text] [Related]
33. Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K/AKT and NF-κB Signaling Pathways. Li N, Sun W, Zhou X, Gong H, Chen Y, Chen D, Xiang F. Biomed Res Int; 2019 Aug 15; 2019():1415809. PubMed ID: 31781591 [Abstract] [Full Text] [Related]
34. Oleanolic acid ameliorates dextran sodium sulfate-induced colitis in mice by restoring the balance of Th17/Treg cells and inhibiting NF-κB signaling pathway. Kang GD, Lim S, Kim DH. Int Immunopharmacol; 2015 Dec 15; 29(2):393-400. PubMed ID: 26514300 [Abstract] [Full Text] [Related]
35. (+)-Catechin Attenuates NF-κB Activation Through Regulation of Akt, MAPK, and AMPK Signaling Pathways in LPS-Induced BV-2 Microglial Cells. Syed Hussein SS, Kamarudin MN, Kadir HA. Am J Chin Med; 2015 Dec 15; 43(5):927-52. PubMed ID: 26227399 [Abstract] [Full Text] [Related]
36. Roxithromycin inhibits nuclear factor kappaB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates experimental colitis in mice. Choi Y, Koh SJ, Lee HS, Kim JW, Gwan Kim B, Lee KL, Kim JS. Exp Biol Med (Maywood); 2015 Dec 15; 240(12):1664-71. PubMed ID: 26088864 [Abstract] [Full Text] [Related]
37. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. Ren Q, Guo F, Tao S, Huang R, Ma L, Fu P. Biomed Pharmacother; 2020 Feb 15; 122():109772. PubMed ID: 31918290 [Abstract] [Full Text] [Related]
38. Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation. Li J, Zhong W, Wang W, Hu S, Yuan J, Zhang B, Hu T, Song G. PLoS One; 2014 Feb 15; 9(2):e87810. PubMed ID: 24504372 [Abstract] [Full Text] [Related]
39. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages. Kim IT, Ryu S, Shin JS, Choi JH, Park HJ, Lee KT. J Cell Biochem; 2012 Jun 15; 113(6):1936-46. PubMed ID: 22234926 [Abstract] [Full Text] [Related]
40. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. Yousef M, Pichyangkura R, Soodvilai S, Chatsudthipong V, Muanprasat C. Pharmacol Res; 2012 Jul 15; 66(1):66-79. PubMed ID: 22475725 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]